News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals
servier.com
May 24, 2025, 09:33

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Servier shared a post on LinkedIn:

“We are thrilled to announce that we have acquired a precision therapy with the potential to be ‘best-in-class’ for acute leukemias from BioNova Pharmaceuticals. This acquisition strengthens our leadership in blood cancer and commitment to developing precision medicine in line with our 2030 strategy. At Servier, we have made oncology one of our priority innovation areas. We invest close to 70% of our R&D budget in oncology, with a view to becoming a focused and innovative player in rare cancer treatments.”

Read the press release.

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

More posts featuring Servier.

Acute leukemias BioNova Pharmaceuticals cancer Headlines OncoDaily Oncology precision therapy Servier
Special Coverage
Blog
May 24, 2025, 09:33
Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals
Blog
May 24, 2025, 09:17
Carolyn Taylor Announced Voices of Impact for Cancer Equity - A Collaborative Effort Between GFC and AORTIC
Blog
May 24, 2025, 09:07
Sakditad Saowapa: Just One Week Until The World’s Biggest Stage For Oncology Science
Insight
May 24, 2025, 09:04
Cancer Institute NSW Welcomed Leaders in Cancer Research at NSW Fellows' Forum 2025
Insight
May 24, 2025, 08:23
UICC Hosts ATOM Coalition 3rd Anniversary Meeting in Geneva
Opinion
May 24, 2025, 07:48
Michael Sapienza: New Study by Emil Lou Underscores the Critical Need for More Colorectal Cancer Research
Science
May 24, 2025, 07:28
Héctor Vaquera: Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma
Insight
May 24, 2025, 07:06
Heidi Ko Will Present a Poster on Immune Expression Profiles of Pancreatic Adenocarcinoma at ASCO 2025
Blog
May 24, 2025, 07:01
Damian Green Shares His Experience as Chief of the Division of Transplantation and Cellular Therapy at Sylvester Cancer Center
Blog
May 24, 2025, 06:43
Danny Burke: Ecancer Will Publish Educational Oncology Resources at the 2025 ASCO Annual Meeting
Blog
May 24, 2025, 06:40
Andrea Anampa-Guzmán Will Amplify Trainee Research on Drug Development, Survivorship Oncology and Global Oncology at ASCO 2025
Blog
May 24, 2025, 06:30
Chandler Park: AVENUES is the New Gold Standard for a Global Medical Education Meeting